This opening segment establishes the clinical context for a 66 year old man with well differentiated, non functioning, ...

Newly updated guidelines on neuroendocrine tumors developed by an expert at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and collaborators provide ...

Please provide your email address to receive an email when new articles are posted on . Median PFS improved by more than 1 year for patients who received radioligand therapy. ORR improved by more than ...

Adding the somatostatin analog lanreotide to the mTOR inhibitor everolimus significantly prolonged progression-free survival in patients with unresectable or recurrent gastroenteropancreatic ...

Stage 1 lung carcinoid tumors are confined to the lung and have not spread to lymph nodes or distant organs. Tumors at this stage are typically small and localized, which often allows for curative ...

Patients with neuroendocrine tumors or neuroblastoma could be treated with a different approach based on a protein that may be a potential biomarker. A specific protein could be a potential biomarker ...

Please provide your email address to receive an email when new articles are posted on . An AACE consensus statement outlines treatment recommendations for MEN1-associated tumors and genetic testing.

If you or a loved one has gastroenteropancreatic neuroendocrine tumors (GEP-NETs), you may be interested in learning about treatment options. One medicine you might hear about is Lutathera (lutetium ...